SGN-CD70A

N/A

Report date: 2024/02/05 13:50:38

Base Information

Drug NameSGN-CD70A

Drug Alias NameSGN-70ASGN-CD70ASGNCD-70A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Cleavable peptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > PBD dimer payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionDNA cross linking agentsAnti-CD70

TargetsCD70 antigenDNA

Therapy Area/IndicationsCarcinoma, Renal CellLymphoma, Mantle-CellLymphoma, Follicular +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSeagen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSeagen Inc

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal CellLymphoma, Mantle-CellLymphoma, Follicular +[4]

Other Information

ATC CodeN/A